Melinda Aldrich Archive — Page 1 of 1
-
July 23, 2020
Criteria for lung cancer screens may be expanded
The U.S. Preventive Services Task Force (USPSTF) is recommending two changes that will nearly double the number of people eligible for lung cancer screening by lowering the age from 55 to 50 and reducing the number of smoking history pack years from 30 to 20. -
April 18, 2019
Team explores fungal infection quandary in lung cancer screenings
Serving a region that lies within the tobacco belt, clinicians at Vanderbilt Health face challenges distinguishing lung cancer from histoplasmosis, a fungal infection that creates cancer-mimicking lesions in the lungs. -
June 29, 2017
Genetics of lung cancer survival
Vanderbilt investigators have conducted a first-of-its-kind genome-wide association study of lung cancer survival in African-Americans. -
August 1, 2013
Study explores race differences of lung cancer risk
Vanderbilt research scientist Melinda Aldrich, Ph.D., MPH, has been awarded a National Institutes of Health Academic Career Award to investigate some of the genetic secrets behind a greater risk of lung cancer among African-Americans compared with other racial and ethnic groups. -
August 7, 2012
Ancestry impacts smoking risk for lungs
Smoking is more detrimental to lung function in individuals with high proportions of African ancestry. -
March 24, 2011
Cancer Center study snuffs out menthol myths
People who smoke mentholated cigarettes are no more likely to develop lung cancer or die from the disease than are smokers of non-mentholated brands, a new study shows.